On Wednesday, Emergent Biosolutions Inc (EBS) stock saw a decline, ending the day at $8.93 which represents a decrease of $-0.29 or -3.15% from the prior close of $9.22. The stock opened at $9.16 and ...

Despite revenue challenges, Emergent BioSolutions Inc (EBS) raises guidance and expands NARCAN distribution to meet growing ...

Emergent said it is separately working on increasing the availability of its overdose reverser on site for businesses.

Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measuresOne-year mark of Ready to ...

Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measuresOne-year mark of Ready to Rescue public awareness campaign to expand awareness, p ...

Emergent Biosolutions Inc (EBS) stock saw a modest uptick, ending the day at $9.35 which represents a slight increase of $0.41 or 4.59% from the prior close of $8.94. The stock opened at $9.04 and ...

Former NFL running back Emmitt Smith explains the need for emergency preparedness during the ongoing opioid crisis.

Global Influenza Vaccine Market was valued at US$ 8.78 billion in 2023 and is projected to hit the market valuation of US$ 22.71 billion by 2032 at a CAGR of 11.07% during the forecast period ...

October 05, 2024, 09:56 am ET, BY Patrick- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...

据贝哲斯咨询发布的2024版铜绿假单胞菌肺炎药物市场分析报告，全球和中国铜绿假单胞菌肺炎药物市场规模在2023年分别达到 亿元（人民币）与 ...

Emergent BioSolutions shows signs of turnaround with restructuring and new contracts in biodefense, but risks remain. Check ...

Emergent BioSolutions Inc.宣布向其执行副总裁、首席财务官兼财务主管Richard S. Lindahl授予特别一次性股权奖励。 董事会薪酬委员会于周三批准授予15,000个限制性股票单位，这些单位将于2025年10月15日归属，前提是Lindahl届时仍在公司任职。